SE0300795D0 - Composition comprising iscom particles and live micro-organisms - Google Patents
Composition comprising iscom particles and live micro-organismsInfo
- Publication number
- SE0300795D0 SE0300795D0 SE0300795A SE0300795A SE0300795D0 SE 0300795 D0 SE0300795 D0 SE 0300795D0 SE 0300795 A SE0300795 A SE 0300795A SE 0300795 A SE0300795 A SE 0300795A SE 0300795 D0 SE0300795 D0 SE 0300795D0
- Authority
- SE
- Sweden
- Prior art keywords
- organisms
- composition
- micro
- live micro
- iscom
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0300795A SE0300795D0 (sv) | 2003-03-24 | 2003-03-24 | Composition comprising iscom particles and live micro-organisms |
ES04723123T ES2379351T3 (es) | 2003-03-24 | 2004-03-24 | Composición que comprende partículas de iscom y microorganismos vivos |
US10/550,026 US7838019B2 (en) | 2003-03-24 | 2004-03-24 | Composition comprising iscom particles and live micro-organisms |
NZ542328A NZ542328A (en) | 2003-03-24 | 2004-03-24 | Use of immune stimulating complex (ISCOM) particles as an adjuvant for an antigenic composition that comprises live micro organisms |
PCT/SE2004/000451 WO2004084941A1 (en) | 2003-03-24 | 2004-03-24 | Composition comprising iscom particles and live micro-organisms |
EP04723123A EP1635867B1 (en) | 2003-03-24 | 2004-03-24 | Composition comprising iscom particles and live micro-organisms |
AT04723123T ATE544471T1 (de) | 2003-03-24 | 2004-03-24 | Zusammensetzung mit iscom-teilchen und lebenden mikroorganismen |
CA2519806A CA2519806C (en) | 2003-03-24 | 2004-03-24 | Composition comprising iscom particles and live micro-organisms |
BRPI0408587-6A BRPI0408587A (pt) | 2003-03-24 | 2004-03-24 | composição compreendendo partìculas de iscom e microrganismos vivos |
AU2004224487A AU2004224487B2 (en) | 2003-03-24 | 2004-03-24 | Composition comprising iscom particles and live micro-organisms |
ZA200506988A ZA200506988B (en) | 2003-03-24 | 2005-08-31 | Composition comprising iscom particles and live micro-organisms |
US12/905,418 US20110081378A1 (en) | 2003-03-24 | 2010-10-15 | Composition comprising iscom particles and live micro-organisms |
US14/146,365 US9205147B2 (en) | 2003-03-24 | 2014-01-02 | Composition comprising iscom particles and live micro-organisms |
US14/933,722 US9901634B2 (en) | 2003-03-24 | 2015-11-05 | Compositions comprising iscom particles and live micro-organisms |
US15/876,630 US10813994B2 (en) | 2003-03-24 | 2018-01-22 | Composition comprising iscom particles and live micro-organisms |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0300795A SE0300795D0 (sv) | 2003-03-24 | 2003-03-24 | Composition comprising iscom particles and live micro-organisms |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0300795D0 true SE0300795D0 (sv) | 2003-03-24 |
Family
ID=20290755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0300795A SE0300795D0 (sv) | 2003-03-24 | 2003-03-24 | Composition comprising iscom particles and live micro-organisms |
Country Status (11)
Country | Link |
---|---|
US (5) | US7838019B2 (sv) |
EP (1) | EP1635867B1 (sv) |
AT (1) | ATE544471T1 (sv) |
AU (1) | AU2004224487B2 (sv) |
BR (1) | BRPI0408587A (sv) |
CA (1) | CA2519806C (sv) |
ES (1) | ES2379351T3 (sv) |
NZ (1) | NZ542328A (sv) |
SE (1) | SE0300795D0 (sv) |
WO (1) | WO2004084941A1 (sv) |
ZA (1) | ZA200506988B (sv) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0300795D0 (sv) | 2003-03-24 | 2003-03-24 | Isconova Ab | Composition comprising iscom particles and live micro-organisms |
BRPI0606481A2 (pt) | 2005-01-20 | 2009-06-30 | Isconova Ab | composição de vacina compreendendo uma proteìna de ligação a fibronectina ou um peptìdeo de ligação a fibronectina |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
WO2011005183A1 (en) * | 2009-07-10 | 2011-01-13 | Isconova Ab | New composition |
GB201016471D0 (en) * | 2010-09-30 | 2010-11-17 | Isis Innovation | Viral vector immunogenic compositions |
CN105555306B (zh) | 2013-09-19 | 2019-12-03 | 诺瓦瓦克斯股份有限公司 | 免疫原性中东呼吸综合征冠状病毒(MERS-CoV)组合物和方法 |
EP3117831A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Peptides for use in promoting transport of glucose into skeletal muscle |
KR102307260B1 (ko) | 2015-07-16 | 2021-10-01 | 뉴리타스 리미티드 | 항염증 펩티드, 및 그의 용도 |
EP3118216A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Cellular growth and proliferation promoting peptides, and uses thereof |
EP3118215A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Anti-inflammatory peptides, and uses thereof |
EP3117830A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Antibacterial peptides, and uses thereof |
WO2018014936A1 (en) | 2016-07-18 | 2018-01-25 | Nuritas Limited | Topical compositions |
EP3329905A1 (en) | 2016-12-05 | 2018-06-06 | Nuritas Limited | Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin |
BR112019011394A2 (pt) | 2016-12-05 | 2019-12-10 | Nuritas Ltd | composições compreendendo peptídeo wkdeagkplvk |
US20210238229A1 (en) | 2018-06-14 | 2021-08-05 | University College Cork - National University Of Ireland, Cork | Peptide for disease treatment |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3775783D1 (de) * | 1986-01-14 | 1992-02-20 | Nederlanden Staat | Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung. |
NZ230747A (en) * | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
GB8919819D0 (en) | 1989-09-01 | 1989-10-18 | Coopers Animal Health | Complexes having adjuvant activity |
NL9002314A (nl) | 1990-10-23 | 1992-05-18 | Nederlanden Staat | Immunogene complexen, in het bijzonder iscoms. |
GB9320668D0 (en) * | 1993-10-07 | 1993-11-24 | Secr Defence | Liposomes containing particulare materials |
JPH10508182A (ja) * | 1994-03-09 | 1998-08-18 | パシフィック バイオテク インターナショナル,インコーポレーテッド | 活性化ウイルス |
AUPM873294A0 (en) * | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
US5676354A (en) * | 1995-07-14 | 1997-10-14 | Fuji Photo Film Co., Ltd. | Sheet film pack |
US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
DE69704011T2 (de) * | 1996-10-09 | 2001-06-07 | Akzo Nobel Nv | Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Sweins (PRRSV) |
AU2003269839B2 (en) | 2002-10-02 | 2006-07-27 | Nordic Vaccine A/S | Composition for vaccination |
SE0300795D0 (sv) | 2003-03-24 | 2003-03-24 | Isconova Ab | Composition comprising iscom particles and live micro-organisms |
-
2003
- 2003-03-24 SE SE0300795A patent/SE0300795D0/sv unknown
-
2004
- 2004-03-24 BR BRPI0408587-6A patent/BRPI0408587A/pt not_active Application Discontinuation
- 2004-03-24 US US10/550,026 patent/US7838019B2/en active Active
- 2004-03-24 EP EP04723123A patent/EP1635867B1/en not_active Revoked
- 2004-03-24 CA CA2519806A patent/CA2519806C/en not_active Expired - Lifetime
- 2004-03-24 AU AU2004224487A patent/AU2004224487B2/en not_active Expired
- 2004-03-24 WO PCT/SE2004/000451 patent/WO2004084941A1/en active Application Filing
- 2004-03-24 ES ES04723123T patent/ES2379351T3/es not_active Expired - Lifetime
- 2004-03-24 AT AT04723123T patent/ATE544471T1/de active
- 2004-03-24 NZ NZ542328A patent/NZ542328A/xx unknown
-
2005
- 2005-08-31 ZA ZA200506988A patent/ZA200506988B/en unknown
-
2010
- 2010-10-15 US US12/905,418 patent/US20110081378A1/en not_active Abandoned
-
2014
- 2014-01-02 US US14/146,365 patent/US9205147B2/en not_active Expired - Lifetime
-
2015
- 2015-11-05 US US14/933,722 patent/US9901634B2/en not_active Expired - Lifetime
-
2018
- 2018-01-22 US US15/876,630 patent/US10813994B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2004084941A1 (en) | 2004-10-07 |
US9901634B2 (en) | 2018-02-27 |
AU2004224487B2 (en) | 2009-08-06 |
CA2519806C (en) | 2012-06-19 |
US9205147B2 (en) | 2015-12-08 |
AU2004224487A1 (en) | 2004-10-07 |
US7838019B2 (en) | 2010-11-23 |
EP1635867A1 (en) | 2006-03-22 |
US20180369369A1 (en) | 2018-12-27 |
US20110081378A1 (en) | 2011-04-07 |
EP1635867B1 (en) | 2012-02-08 |
US20080095795A1 (en) | 2008-04-24 |
NZ542328A (en) | 2009-10-30 |
CA2519806A1 (en) | 2004-10-07 |
BRPI0408587A (pt) | 2006-03-21 |
US20160114034A1 (en) | 2016-04-28 |
US10813994B2 (en) | 2020-10-27 |
ES2379351T3 (es) | 2012-04-25 |
ZA200506988B (en) | 2006-07-26 |
US20140120131A1 (en) | 2014-05-01 |
US20200323979A9 (en) | 2020-10-15 |
ATE544471T1 (de) | 2012-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0300795D0 (sv) | Composition comprising iscom particles and live micro-organisms | |
MX336500B (es) | Insecticida para uso agricola u horticola y metodo para su uso. | |
MX2007010045A (es) | Pirazolopirimidinas. | |
SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
PL2018441T3 (pl) | Mikroorganizmy znakowane i sposoby znakowania | |
PH12014500053A1 (en) | Proteasome inhibitors | |
IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
EA200700965A1 (ru) | Трегалоза и/или изомальтулоза в качестве носителя для сухой ароматической композиции | |
EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
EP1784639A4 (en) | PROCESS FOR PREPARING FREEZERTED BLOOD PLATES, FLUIDIZED BLOOD PLATES, COMPOSITIONS AND USE METHOD | |
DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
EP1594536A4 (en) | ADJUVANT INFLUENZA VACCINE | |
DE502005008971D1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
DE502004002571D1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
MX2007007288A (es) | Desacilacion de lps en bacterias gram negativas. | |
ATE453328T1 (de) | Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
ATE384437T1 (de) | N-thio-nicotinamid derivate und verwandte verbindungen zur verwendung als schädlingsbekämpfungsmittel | |
EA200600021A1 (ru) | Пиразолопиримидины | |
CR8443A (es) | Pirazolopirimidinas | |
AU2001238332A1 (en) | Method of sterilizing articles | |
CY1109657T1 (el) | Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης | |
WO2007005659A3 (en) | Methods and compositions for culturing keratinocytes |